Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1126/scitranslmed.3005975 http://scihub22266oqcxt.onion/10.1126/scitranslmed.3005975 C4374645!4374645 !25031271     free     free     free Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\25031271 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Sci+Transl+Med 2014 ; 6 (245 ): 245sr2 Nephropedia Template TP {{tp|p=25031271 |t=2014. Cell and tissue engineering for liver disease |pdf=|usr=}}{{25031271 }} gab.com Text Cell and tissue engineering for liver disease JO: Sci Transl Med http://www.kidney.de/pget.php?&tw=1&pmid=25031271 #FOAvip Despite the tremendous hurdles presented by the complexity of the liver's structure and function, advances in liver physiology, stem cell biology and reprogramming, and the engineering of tissues and devices are accelerating the development of cell-based therapies for treating liver disease and liver failure. This State of the Art Review discusses both the near- and long-term prospects for such cell-based therapies and the unique challenges for clinical translation. Twit Text FOAVip Cell and tissue engineering for liver disease ????Sci Transl Med http://www.kidney.de/pget.php?&tw=1&pmid=25031271 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=25031271 #FOAvip English Wikipedia <ref>{{Cite pmid|25031271 }}</ref> Cell and tissue engineering for liver disease #MMPMID25031271 Bhatia SN ; Underhill GH ; Zaret KS ; Fox IJ Sci Transl Med 2014[Jul]; 6 (245 ): 245sr2 PMID25031271 show ga Despite the tremendous hurdles presented by the complexity of the liver's structure and function, advances in liver physiology, stem cell biology and reprogramming, and the engineering of tissues and devices are accelerating the development of cell-based therapies for treating liver disease and liver failure. This State of the Art Review discusses both the near- and long-term prospects for such cell-based therapies and the unique challenges for clinical translation. |Animals [MESH] |Cell Engineering/*methods [MESH] |Disease Models, Animal [MESH] |Humans [MESH] |Liver Diseases/*therapy [MESH] |Liver/pathology [MESH] |Tissue Engineering/*methods [MESH]Cell and tissue engineering for liver disease (epmc).pdf DeepDyve Pubget Overpricing